ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,489 | +1158.3% | 10,868 | +2902.2% | 0.02% | +1400.0% |
| Q2 2020 | $18,000 | -52.6% | 362 | -59.0% | 0.00% | 0.0% |
| Q4 2019 | $38,000 | +5.6% | 884 | -34.8% | 0.00% | -50.0% |
| Q2 2019 | $36,000 | -30.8% | 1,355 | -30.1% | 0.00% | -33.3% |
| Q1 2019 | $52,000 | -93.3% | 1,939 | -96.2% | 0.00% | -93.9% |
| Q2 2018 | $774,000 | -13.2% | 50,700 | +58.4% | 0.05% | -41.7% |
| Q2 2017 | $892,000 | +82.0% | 32,000 | +107.8% | 0.08% | +64.7% |
| Q3 2016 | $490,000 | -17.2% | 15,400 | -35.1% | 0.05% | -48.0% |
| Q4 2013 | $592,000 | -6.3% | 23,720 | +3.0% | 0.10% | -3.9% |
| Q3 2013 | $632,000 | -40.0% | 23,020 | -60.3% | 0.10% | -54.9% |
| Q2 2013 | $1,053,000 | – | 58,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |